CE Form 4: Director Scott McDougald acquires 2,000 shares

Rhea-AI Filing Summary

Celanese Corporation (CE) director Scott McDougald reported a non-derivative purchase of 2,000 shares on 08/14/2025 at a price of $40.8935 per share, increasing his direct beneficial ownership to 20,376 shares. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions or additional remarks were reported.

Positive

• Director purchase disclosed: Report shows a purchase of 2,000 shares on 08/14/2025 at $40.8935.
• Clear ownership update: Direct beneficial ownership after the trade is stated as 20,376 shares.
• Proper filing execution: Form 4 was signed (by attorney-in-fact) and includes required transaction details.

Negative

• None.

Insights

Securities Analyst

TL;DR: Director executed a straightforward open-market purchase of 2,000 shares, modestly increasing direct holdings.

The filing documents a single non-derivative transaction: a purchase (code P) of 2,000 shares at $40.8935 on 08/14/2025, bringing direct ownership to 20,376 shares. The disclosure was executed via attorney-in-fact and contains no derivative activity, amendments, or additional explanatory remarks. For investors, this is a routine Section 16 disclosure of insider activity without further material context provided in the form.

Corporate Governance Expert

TL;DR: Routine insider buy reported by a director; filing is complete and shows no irregularities.

The Form 4 indicates the reporting person is a director and filed individually. The transaction type, number of shares, price, and resulting ownership are all specified, and the form was signed by an authorized attorney-in-fact. There are no indications of joint filings, derivative positions, or corrective amendments. This appears to be a standard compliance disclosure under Section 16.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sutton Scott McDougald

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W LAS COLINAS BLVD, SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		P		2,000	A	$40.8935	20,376	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Scott McDougald Sutton	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celanese (CE) report on this Form 4?

The form reports a purchase of 2,000 shares by director Scott McDougald on 08/14/2025 at $40.8935 per share.

How many shares does Scott McDougald beneficially own after the reported trade?

He beneficially owns 20,376 shares following the 08/14/2025 transaction.

Was the Form 4 filed jointly or by one reporting person?

The form was filed by one reporting person (individual filing indicated).

Are there any derivative transactions reported on this Form 4 for CE?

No derivative securities (options, warrants, convertible securities) are reported in Table II of the form.

Who signed the Form 4 and when was it dated?

The form was signed by Christine Dryden, Attorney-in-Fact for Scott McDougald, dated 08/18/2025.